Finding the ‘Guilty’ Gene Variant of Sporadic Parkinson’s Disease Via CRISPR/Cas9

被引:0
|
作者
Shenzhao Lu
Jiawei Zhou
机构
[1] Chinese Academy of Sciences,Institute of Neuroscience, State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences
来源
Neuroscience Bulletin | 2017年 / 33卷
关键词
Parkinson’s disease; Genetic variant; CRISPR/Cas9;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) is a common neurodegenerative disorder affecting millions of people worldwide, but its cause and pathogenesis are still not fully understood. Earlier studies have shown that SNCA, which encodes α-synuclein, is one of the key genes associated with PD. Single-nucleotide polymorphism (SNP) variants of SNCA are thought to be correlated with disease onset. The underlying mechanisms however are enigmatic. A recent study published in Nature revealed that one of the SNP variants in the SNCA non-coding element elevated α-synuclein expression in human neurons by reducing the binding efficiency of transcription factors, demonstrating a previously uncharted role for SNPs in the pathogenesis of PD.
引用
收藏
页码:115 / 117
页数:2
相关论文
共 50 条
  • [31] CRISPR/Cas9 Technology: Applications and Human Disease Modeling
    Martinez-Lage, Marta
    Torres-Ruiz, Raul
    Rodriguez-Perales, Sandra
    CRISPR IN ANIMALS AND ANIMAL MODELS, 2017, 152 : 23 - 48
  • [32] Reversible Regulation of Polyubiquitin Gene UBC via Modified Inducible CRISPR/Cas9 System
    Han, Seung-Woo
    Jung, Byung-Kwon
    Park, So-Hyun
    Ryu, Kwon-Yul
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (13):
  • [33] Generation of golden goldfish Carassius auratus via tyrosinase gene targeting by CRISPR/Cas9
    Li, Huijuan
    Wang, Xiaowen
    Zhang, Rong
    Liu, Lili
    Zhu, Hua
    AQUACULTURE, 2024, 583
  • [34] Efficient gene editing in adult mouse livers via adenoviral delivery of CRISPR/Cas9
    Cheng, Ranran
    Peng, Jin
    Yan, Yonghong
    Cao, Peili
    Wang, Jiewei
    Qiu, Chen
    Tang, Lichun
    Liu, Di
    Tang, Li
    Jin, Jianping
    Huang, Xingxu
    He, Fuchu
    Zhang, Pumin
    FEBS LETTERS, 2014, 588 (21) : 3954 - 3958
  • [35] Editing the genome of hiPSC with CRISPR/Cas9: disease models
    Bassett, Andrew R.
    MAMMALIAN GENOME, 2017, 28 (7-8) : 348 - 364
  • [36] Genome engineering and disease modeling via programmable nucleases for insulin gene therapy; promises of CRISPR/Cas9 technology
    Eksi, Yunus E.
    Sanlioglu, Ahter D.
    Akkaya, Bahar
    Ozturk, Bilge Esin
    Sanlioglu, Salih
    WORLD JOURNAL OF STEM CELLS, 2021, 13 (06): : 485 - 502
  • [37] Application of CRISPR/Cas9 System in the Treatment of Alzheimer's Disease and Neurodegenerative Diseases
    Rahimi, Araz
    Sameei, Parsa
    Mousavi, Sana
    Ghaderi, Kimia
    Hassani, Amin
    Hassani, Sepideh
    Alipour, Shahriar
    MOLECULAR NEUROBIOLOGY, 2024, 61 (11) : 9416 - 9431
  • [38] CRISPR/Cas9 Delivery Potentials in Alzheimer's Disease Management: A Mini Review
    Hanafy, Amira Sayed
    Schoch, Susanne
    Lamprecht, Alf
    PHARMACEUTICS, 2020, 12 (09) : 1 - 14
  • [39] CRISPR/Cas9-mediated gene editing in human zygotes using Cas9 protein
    Tang, Lichun
    Zeng, Yanting
    Du, Hongzi
    Gong, Mengmeng
    Peng, Jin
    Zhang, Buxi
    Lei, Ming
    Zhao, Fang
    Wang, Weihua
    Li, Xiaowei
    Liu, Jianqiao
    MOLECULAR GENETICS AND GENOMICS, 2017, 292 (03) : 525 - 533
  • [40] Combining CRISPR/Cas9 and rAAV Templates for Efficient Gene Editing
    Kaulich, Manuel
    Dowdy, Steven F.
    NUCLEIC ACID THERAPEUTICS, 2015, 25 (06) : 287 - 296